Policy analysis outlines a cooperative governance model for pathogen genomics in global health surveillance, highlighting the need for equitable data sharing and capacity building.
This article examines pathogen genomics as a critical component of global health security and cooperative preparedness. It analyzes how molecular epidemiology supports outbreak detection, transmission analysis, antimicrobial-resistance surveillance, and evidence-informed response, while addressing governance challenges involving capacity asymmetry, data sovereignty, benefit-sharing, privacy, contested interpretations, and public trust. It article advances a diplomatic governance approach that treats genomic surveillance as cooperative risk infrastructure. It proposes a Genomic Surveillance Compact linking regional capacity, interoperability, tiered data access, reciprocal benefit-sharing, methodological transparency, privacy safeguards, and genomics-to-action guidance. Analyses span respiratory viruses, vector-borne diseases, zoonoses, and antimicrobial resistance, with performance assessed through timeliness, representativeness, actionability, and equity.
No takes yet. Share an insight, caveat, or question.
Ikenna C. Okafor (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: